UKHSA (UK) · Jun 12, 2026
Andes hantavirus: epidemiology, outbreaks and guidance
The epidemiology, symptoms, diagnosis and management of Andes hantavirus infection.
Latest medical news · page 6
The latest headlines across every section, pulled from official and open-access sources.
UKHSA (UK) · Jun 12, 2026
Official Statistics: Weekly all-cause mortality surveillance: week ending 14 June 2026
How the actual number of deaths in England compare with expected numbers for each week.
FDA MedWatch · Jun 12, 2026
Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP
Medline is correcting affected convenience kits by removing recalled Bupivacaine Hydrochloride in Dextrose Injection components.
FDA MedWatch · Jun 12, 2026
Beekeeper’s Naturals Issues Voluntary Nationwide Recall of Beekeeper’s Naturals Saline Nasal Spray Sold Through Amazon Due to Microbial Contamination
FOR IMMEDIATE RELEASE – June 11, 2026, Covina, CA - Beekeeper’s Naturals is voluntarily recalling lot # 5950, Exp. Date 02/2028 of Beekeeper’s Naturals Saline Nasal Spray, sold only through Amazon, to the consumer level. This lot, produced at a third-party manufacturer, tested above our acceptable
CDC Emerging Infections · Jun 12, 2026
Emerging Risk for Human T-Cell Leukemia Virus Type 1 Transmission with HIV-Positive Breastfeeding Support
A. Meybeck et al.
FDA MedWatch · Jun 12, 2026
Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication
Read the FDA’s recommendations related to Accolade pacemaker devices by Boston Scientific and a potential need for early device replacement.
MedCity News · Jun 12, 2026
Abridge Goes Beyond Documentation: 4 Updates
Clinical AI startup Abridge held a New York City event to signal it’s done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, new capabilities for its platform, and the intent to help mediate the relationship between payers and providers. The post Abridge Goes Beyond Documentation: 4 Updates appeared first on MedCity News .
JAMA Network Open · Jun 12, 2026
Comprehensive Background Checks and Firearm Purchaser Licensing
Public Health
JAMA Network Open · Jun 12, 2026
Closing the Gaps in Early Sepsis Fluid Resuscitation
Critical Care Medicine
JAMA Network Open · Jun 12, 2026
Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV
This cross-sectional study examines the use of long-acting injectable antiretroviral therapy among Medicare beneficiaries with HIV and characterizes the differences between people receiving oral antiretroviral therapy vs long-acting injectable antiretroviral therapy.
JAMA Network Open · Jun 12, 2026
Telemedicine-Based Diabetes Management for Incarcerated Individuals
This quality improvement study examines the outcomes associated with a pilot telemedicine program for incarcerated individuals with diabetes in Illinois.
JAMA Network Open · Jun 12, 2026
Chronic Conditions and Mortality in Medicare Before and After COVID-19
This cross-sectional study examines chronic conditions and mortality in fee-for-service Medicare and Medicare Advantage in 2019 and 2022, before and after the COVID-19 pandemic.
JAMA Network Open · Jun 12, 2026
Visual Impairment and Cardiovascular Risk Factors in Hispanic and Latino Adults
This cross-sectional study estimates the prevalence of visual impairment in US Hispanic and Latino adults with diverse backgrounds and explores whether it is associated with risk factors for cardiovascular disease.
JAMA Network Open · Jun 12, 2026
Point-of-Sale Background Check Policies and County Firearm Homicide Rates
This cross-sectional study estimates the association between implementation of point-of-sale comprehensive background check policies in 6 states—Colorado, Delaware, New Mexico, Oregon, Vermont, and Washington—and county-level firearm homicide rates.
JAMA Network Open · Jun 12, 2026
Media Consumption and Distress in Communities Affected by Mass Violence
This cross-sectional study of survey data from adults living in communities impacted by mass violence examines whether greater mass violence incident–related media consumption is associated with worry and avoidance behaviors associated with concerns about future violence.
JAMA Network Open · Jun 12, 2026
Comorbidities, Weight-Based Initial Fluid Resuscitation, and Sepsis Mortality
This cohort study evaluates whether administration of 30 mL/kg or more of fluid within 6 hours of hospital arrival is associated with reduced 30-day mortality in adults with community-onset sepsis.
JAMA Network Open · Jun 12, 2026
National Institutes of Health–Supported Research on Ultraprocessed Foods
This Special Communication assesses National Institutes of Health–supported research projects focusing on ultraprocessed foods (UPF) for fiscal years 2016 to 2025 to identify critical gaps in UPF research and explore opportunities for advancements in the field.
DHSC (UK) · Jun 11, 2026
Cycling and walking boom with £4.5 billion for thousands of new routes and safer crossings
Strategy aims to deliver 5,000 new walking, wheeling and cycling routes and 10,000 safer crossings over the next 5 years.
UKHSA (UK) · Jun 11, 2026
Thousands of young people to be offered 2-dose MenB vaccine
Two-dose MenB vaccine to be offered to young people ahead of the autumn as part of a one-off vaccination programme in England.
MedCity News · Jun 11, 2026
Healthcare Leader to CMS on New Medicaid Eligibility Requirements: Give States an Extension
At AHIP 2026, healthcare leaders raised concerns about CMS’ new Medicaid eligibility requirements, with one urging the agency to give states more time to implement them. The post Healthcare Leader to CMS on New Medicaid Eligibility Requirements: Give States an Extension appeared first on MedCity News .
FDA Recalls · Jun 11, 2026
Total Nutrition Inc. Expands Recall of TNVitamins and Doctor’s Pride Ultra Potent Complete Green Superfood Moringa Capsules Because of Possible Health Risk Following Further Supply Chain Review
Total Nutrition Inc. of Deer Park, NY is voluntarily expanding its recall of TNVitamins and Doctor's Pride Ultra Potent Complete Green Superfood Moringa Capsules due to the potential to be contaminated with Salmonella. This expansion follows an ongoing supply chain investigation that identified addi
FDA Drugs · Jun 11, 2026
Frequently Requested or Proactively Posted Drug-Specific and Other Records
Frequently requested or proactively posted drug-specific and other records
FDA Drugs · Jun 11, 2026
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
Section 505B(d)(1) requires FDA to send a PREA Non-Compliance letter to sponsors who have failed to submit their pediatric assessments required under PREA by the final due date, have failed to seek or obtain a deferral or deferral extension.
FDA Drugs · Jun 11, 2026
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
International Council for Harmonisation - Safety